Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 22;12(2):e053837. doi: 10.1136/bmjopen-2021-053837

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Associations between regular use of psychotropic medications (two or more prescriptions) between 2013 and 2016, and type of hormonal contraceptives used in 2017. (A) antipsychotics; (B) anxiolytics; (C) hypnotics/sedatives; (D) antidepressants. Results are from multinomial logistic regression models among HC users. Model 1 is the unadjusted model; Model 2 is Model 1 adjusted for age, marital and socioeconomic status, education and income level; Model 3 is Model 2 adjusted for abortion and pregnancy in 2016–2017. Reference category: G03AA, progestogens and oestrogens, fixed combinations for systemic use—including monophasic combined oral contraceptives and transdermal patch. G02BA, intrauterine device with progestogen; G02BB, vaginal ring with progestogen and oestrogen; G03AB, progestogens and oestrogens, sequential preparations for systemic use; G03AC, progestogens for systemic use; G03HB01, cyproterone and oestrogen. HC, hormonal contraception; RRR, relative risk ratio.